Rationale of the multidrug regimens recommended by a World Health Organization Study Group on Chemotherapy of Leprosy for Control Programs.
D003622:Dapsone / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*
D007917:Leprostatic Agents; D003622:Dapsone